SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

PHAT — Phathom Pharmaceuticals, Inc.

NASDAQ

FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

JUL 30, 2026

REVENUE

$74.3M +27.4%

NET MARGIN

-23.7% +28.4 PTS

EPS

-$0.21 +43.2%

FREE CASH FLOW

-$2.0M +87.4%

No summary has been written for this call yet.